Three compounds isolated from tuberculosis’s fungal foes killed cultured cells of the bacterium that causes the disease in ...

Philips and the Mayo Clinic have launched a new research collaboration focused on applying artificial intelligence to MRI ...

Human genetics biotech Maze Therapeutics has navigated the biotech world’s tricky fundraising landscape to land a $115 ...

Siemens Healthineers is rolling out artificial intelligence programs through its ultrasound platforms that automatically ...

After pausing work on a rare cancer asset, Relay Therapeutics is passing the baton to Elevar Therapeutics. The two have ...

Gilead isn’t the only Big Pharma to take an interest in Tubulis’ ADC tech. BMS paid the company $23 million upfront in April ...

Kinevant Sciences, a Roivant spinout designed to test an investigational monoclonal antibody, has reported that the asset ...

Chicago’s Cour Pharmaceuticals—recently honored as one of Fierce Biotech’s 2024 Fierce 15—is bringing its immunology mission ...

The outlay, plus up to $1.1 billion in milestones, has secured Takeda ex-China rights to a molecule that could compete with ...

Bristol Myers Squibb has enlisted three-year-old Massachusetts biotech AI Proteins to use its artificial intelligence-driven ...

Ipsen has gambled up to $610 million on a new class of bispecific T-cell engagers. The biobuck bet has landed the French ...

Physics, maker of diagnostic radiopharmaceuticals and molecular imaging agents. | GE HealthCare plans to take full control of ...